COSCIENS Biopharma Inc.
CSCIF- Exchange
- OTC
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations
- SEC CIK
- 0001113423
No open-market purchases or sales by COSCIENS Biopharma Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding COSCIENS Biopharma Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 0 | 9 | +9 |
| Shares | 0 | 16.7K | +16.7K |
| Value | $0 | $61.9K | +$61.9K |
New holders (9)
Institutions that held COSCIENS Biopharma Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| National Bank of Canada | 5,796 | $21.7K | 0.00% |
| Federation des caisses Desjardins du Quebec | 4,536 | $16.9K | 0.00% |
| TD Waterhouse Canada Inc. | 3,717 | $13.8K | 0.00% |
| Royal Bank of Canada | 2,527 | $9.00K | 0.00% |
| Advisor Group Holdings, Inc. | 50 | $185 | 0.00% |
| Tower Research Capital LLC (TRC) | 38 | $142 | 0.00% |
| Truvestments Capital LLC | 22 | $83 | 0.00% |
| Planning Capital Management Corp | 2 | $8 | 0.00% |
| Danske Bank A/S | 2 | $7 | 0.00% |
Sold out (0)
Institutions that held COSCIENS Biopharma Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
None.